Nonequilibrium activation of a G-protein-coupled receptor

Molecular Pharmacology

Volumn 81, Issue 6, 2012, Pages 770-777

  Ambrosio, Manuela ^a   Lohse, Martin J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; NORADRENALIN;

ARTICLE; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL LINE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; KINETICS; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84861423107     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.077693     Document Type: Article

References (41)

1. Adler CH, Meller E, and Goldstein M (1987) Receptor reserve at the alpha-2 adrenergic receptor in the rat cerebral cortex. J Pharmacol Exp Ther 240:508-515. (Pubitemid 17018433)
2. Agneter E, Drobny H, and Singer EA (1993) Central α2-autoreceptors: agonist dissociation constants and recovery after irreversible inactivation. Br J Pharmacol 108:370-375. (Pubitemid 23032541)
3. Agneter E, Singer EA, Sauermann W, and Feuerstein TJ (1997) The slope parameter of concentration-response curves used as a touchstone for the existence of spare receptors. Naunyn Schmiedebergs Arch Pharmacol 356:283-292. (Pubitemid 27376457)
4. Ariens EJ, van Rossum J, and Koopman PC (1960) Receptor reserve and threshold phenomena. I. Theory and experiments with autonomic drugs tested on isolated organs. Arch Int Pharmacodyn Ther 127:459-478.
5. Bevan JA, Laher I, and Rowan R (1987) Some implications of the high intrasynaptic norepinephrine concentrations in resistance arteries. Blood Vessels 24:137-140. (Pubitemid 17096541)
6. Bevan JA, Tayo FM, Rowan RA, and Bevan RD (1984) Presynaptic alpha-receptor control of adrenergic transmitter release in blood vessels. Fed Proc 43:1365-1370. (Pubitemid 14173502)
7. Black JW, Leff P, Shankley NP, and Wood J (1985) An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol 84:561-571. (Pubitemid 15169246)
8. + channel currents. J Biol Chem 276:47512-47517.
9. Bünemann M, Frank M, and Lohse MJ (2003) Gi protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc Natl Acad Sci USA 100:16077-16082. (Pubitemid 38021117)
10. Clark AJ (1933) The Mode of Action of Drugs on Cells, E Arnold Co., London.
11. Colquhoun D (2007) What have we learned from single ion channels? J Physiol 581:425-427.
12. 2-adrenergic receptors. Mol Pharmacol 32:65-72.
13. 2-adrenoceptor density and function following irreversible antagonism with EEDQ. Br J Pharmacol 112:855-860.
14. Hein L (2006) Adrenoceptors and signal transduction in neurons. Cell Tissue Res 326:541-551.
15. Hein P, Frank M, Hoffmann C, Lohse MJ, and Bünemann M (2005) Dynamics of receptor/G protein coupling in living cells. EMBO J 24:4106-4114. (Pubitemid 41752879)
16. s activation is time-limiting in initiating receptor-mediated signaling. J Biol Chem 281:33345-33351.
17. Hoffmann C, Gaietta G, Bünemann M, Adams SR, Oberdorff-Maass S, Behr B, Vilardaga JP, Tsien RY, Ellisman MH, and Lohse MJ (2005) A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nat Methods 2:171-176. (Pubitemid 41122123)
18. Hoffmann C, Gaietta G, Zürn A, Adams SR, Terrillon S, Ellisman MH, Tsien RY, and Lohse MJ (2010) Fluorescent labeling of tetracysteine-tagged proteins in intact cells. Nat Protoc 5:1666-1677.
19. Hulme EC and Trevethick MA (2010) Ligand binding assays at equilibrium: validation and interpretation. Br J Pharmacol 161:1219-1237.
20. + channels. J Gen Physiol 133:347-359.
21. Kenakin T (2002) Efficacy at G-protein-coupled receptors. Nat Rev Drug Discov 1:103-110.
22. Lefkowitz RJ (2000) The superfamily of heptahelical receptors. Nat Cell Biol 2:E133-E136.
23. Lenox RH, Ellis J, Van Riper D, and Ehrlich YH (1985) Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet: evidence for a receptor reserve. Mol Pharmacol 27:1-9. (Pubitemid 15162378)
24. Lohse MJ, Hein P, Hoffmann C, Nikolaev VO, Vilardaga JP, and Bünemann M (2008a) Kinetics of G-protein-coupled receptor signals in intact cells. Br J Pharmacol 153 (Suppl 1):S125-S132. (Pubitemid 351341010)
25. Lohse MJ, Nikolaev VO, Hein P, Hoffmann C, Vilardaga JP, and Bünemann M (2008b) Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors. Trends Pharmacol Sci 29:159-165.
26. Maier-Peuschel M, Frölich N, Dees C, Hommers LG, Hoffmann C, Nikolaev VO, and Lohse MJ (2010) A fluorescence resonance energy transfer-based M2 muscarinic receptor sensor reveals rapid kinetics of allosteric modulation. J Biol Chem 285:8793-8800.
27. Molinoff PB, Wolfe BB, and Weiland GA (1981) Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes. Life Sci 29:427-443. (Pubitemid 11005430)
28. Nickerson M (1956) Receptor occupancy and tissue response. Nature 178:697-698.
29. i-protein heterotrimer. J Biol Chem 281:24506-24511.
30. Park J, Kile BM, and Wightman RM (2009) In vivo voltammetric monitoring of norepinephrine release in the rat ventral bed nucleus of the stria terminalis and anteroventral thalamic nucleus. Eur J Neurosci 30:2121-2133.
31. Park J, Takmakov P, and Wightman RM (2011) In vivo comparison of norepinephrine and dopamine release in rat brain by simultaneous measurements with fast-scan cyclic voltammetry. J Neurochem 119:932-944.
32. Philipp M and Hein L (2004) Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes. Pharmacol Ther 101:65-74. (Pubitemid 38068526)
33. Philippu A and Matthaei H (1988) Transport and storage of catecholamines in vesicles. Handb Exp Pharmacol 90:1-42.
34. 2-adrenergic receptor. J Biol Chem285:36188-36198.
35. Ruffolo RR Jr (1986) Spare α adrenoceptors in the peripheral circulation: excitationcontraction coupling. Fed Proc 45:2341-2346.
36. 2-adrenoceptors of rat vas deferens using operational and null approaches. Eur J Pharmacol 258:229-238.
37. Severne Y, Ijzerman A, Nerme V, Timmerman H, and Vauquelin G (1987) Shallow agonist competition binding curves for β-adrenergic receptors: the role of tight agonist binding. Mol Pharmacol 31:69-73. (Pubitemid 17016419)
38. Vilardaga JP, Bünemann M, Krasel C, Castro M, and Lohse MJ (2003) Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat Biotechnol 21:807-812. (Pubitemid 36791401)
39. Vilardaga JP, Steinmeyer R, Harms GS, and Lohse MJ (2005) Molecular basis of inverse agonism in a G protein-coupled receptor. Nat Chem Biol 1:25-28.
40. Weiland GA and Molinoff PB (1981) Quantitative analysis of drug-receptor interactions. I. Determination of kinetic and equilibrium properties. Life Sci 29:313-330. (Pubitemid 12224162)
41. 2A-adrenergic receptor activation reveals distinct agonist-specific conformational changes. Mol Pharmacol 75:534-541.